Dr. Joel Lippman is Noven’s Chief Operating Officer and Chief Medical Officer. He is an obstetrician-gynecologist certified by the American Board of Obstetrics and Gynecology with nearly 30 years' experience in research and development, clinical development, and medical affairs in the pharmaceutical and medical device industries. Dr. Lippman previously served as Noven’s Executive Vice President – Product Development & Chief Medical Officer from 2008 through 2016. Prior to joining Noven, Dr. Lippman served as Worldwide Vice President – Medical Affairs & Chief Medical Officer and a member of the Global Management Board at Ethicon, Inc., a Johnson & Johnson company. Earlier, he served as Vice President – Clinical Trials at Ortho-McNeil Pharmaceutical, Inc., also a Johnson & Johnson company, and held a number of clinical development, medical affairs, and related roles at Wyeth-Ayerst Laboratories. Dr. Lippman holds a Medical Degree from New York Medical College and a Masters in Public Health from Harvard University School of Public Health, and is a Fellow of the American College of Obstetricians and Gynecologists.